Skip to main content

Vito Quaranta Archives

$8.1 million grant funds new center to research highly aggressive form of lung cancer

Jun. 8, 2018—A five-year National Cancer Institute grant will fund an interdisciplinary research center for the study of small cell lung cancer, a highly aggressive, incurable form of the disease.

Read more


“Idling” cancer cells may return

Apr. 11, 2018—Vanderbilt investigators have discovered that cancer treatment induces an “idling” state for cells, which could promote resistance to treatment.

Read more


Melanoma study finds new way to enhance targeted therapies

Mar. 9, 2017—With the help of a drug formerly used to treat HIV/AIDS, researchers at Vanderbilt University Medical Center (VUMC) have found a way to make melanoma cells more vulnerable to targeted anti-cancer therapy.

Read more


Current cancer drug discovery method flawed: VUMC study

May. 5, 2016—The primary method used to test compounds for anti-cancer activity in cells is flawed, Vanderbilt University researchers reported May 2 in Nature Methods.

Read more


Ten Vanderbilt faculty members elected AAAS fellows

Nov. 23, 2015—Ten members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science.

Read more


Method may refine personalized trials for cancer therapy

Aug. 16, 2012—A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments.

Read more


Protein ‘scissors’ cut path for cancer

Feb. 22, 2011—The protein matriptase "cuts" a key component of the prostate tissue barrier and may be involved in prostrate cancer progression, new research finds.

Read more


Upcoming Events

MORE EVENTS »